PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Derin Keskin

Dana-Farber Cancer Institute

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

JUL 28, 2026 · JOURNAL ARTICLE

Roadmap of MCPyV T-antigens for off-the-shelf therapeutic MCC vaccine development 2309574

The Journal of Immunology

This is an epitope discovery and validation study using in vitro immunological assays and patient-derived models, establishing feasibility for vaccine development but lacking clinical efficacy data or Phase trial results.

PreliminaryDerin Keskin Katarina Pinjušić Immunotherapy and Immune Responses

Reported

MCC two-year mortality in distant…approaching 20%

Proportion of MCC cases MCPyV-dri…more than 80%

HLA-I monoallelic lines tested95

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support